Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Shares Outstanding (Weighted Average): 2019-2024

Historic Shares Outstanding (Weighted Average) for IDEAYA Biosciences (IDYA) over the last 6 years, with Dec 2024 value amounting to $86.4 million.

  • IDEAYA Biosciences' Shares Outstanding (Weighted Average) rose 3.74% to $87.6 million in Q3 2025 from the same period last year, while for Jun 2025 it was $87.6 million, marking a year-over-year increase of 15.72%. This contributed to the annual value of $86.4 million for FY2024, which is 34.09% up from last year.
  • As of FY2024, IDEAYA Biosciences' Shares Outstanding (Weighted Average) stood at $86.4 million, which was up 34.09% from $64.5 million recorded in FY2023.
  • In the past 5 years, IDEAYA Biosciences' Shares Outstanding (Weighted Average) registered a high of $86.4 million during FY2024, and its lowest value of $29.1 million during FY2020.
  • For the 3-year period, IDEAYA Biosciences' Shares Outstanding (Weighted Average) averaged around $66.3 million, with its median value being $64.5 million (2023).
  • Data for IDEAYA Biosciences' Shares Outstanding (Weighted Average) shows a peak YoY soared of 42.98% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows IDEAYA Biosciences' Shares Outstanding (Weighted Average) stood at $29.1 million in 2020, then surged by 32.43% to $38.5 million in 2021, then increased by 24.98% to $48.1 million in 2022, then surged by 33.97% to $64.5 million in 2023, then surged by 34.09% to $86.4 million in 2024.